STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
Confidential tips can be sent on Signal at JasonMast.77. RA Capital and a fleet of other investors are putting $175…
Recent health headlines from STAT News.

The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound shock” last year, according to a new report from UNAIDS.

Confidential tips can be sent on Signal at JasonMast.77. RA Capital and a fleet of other investors are putting $175…

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…

Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics,…

An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds

Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple…

From new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.

Centers for Disease Control and Prevention logged 2,318 cases of measles as of Thursday, according to an agency update…

Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.

“Consumers should not be faced with a trade-off between nutrition and food safety,” writes Susan Mayne, former…

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction,…

A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of…

Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products and…

Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior…

The Trump administration said it was deferring more than $1 billion in Medicaid payments to Minnesota and California…

Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular…

He previously served as senior adviser for children, youth, and families at the Substance Abuse and Mental Health…

MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk,…

Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis…

The government of Uganda has gone quiet on an outbreak of the deadly Marburg virus that it reported late last month,…

Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.

FDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readout

The Ebola outbreak in eastern Congo “continues to outpace the response efforts,” the WHO’s emergencies chief said on…

OpinionFirst Opinion It looks like your doctor and talks like your doctor. But it’s not your doctor Deepfakes raise a…

America's hidden alcohol epidemic — the toll, emerging risks, shifting usage, and economic stakes — broken down in 10…

The results of a recent AI competition show that better data trumps bigger models when it comes to predicting…

They also reviewed scientific literature, addiction treatment protocols, laws, public health guidance, and lobbying…

A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead…

From STAT's AAIC in 30 newsletter: Researchers focus on tau, and progress on crossing the blood-brain barrier.

Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer treatment…

Diagnosis The crumbling employer-based health insurance system You’re reading STAT’s D.C. You can reach John on Signal…

Anthropic CEO talks drug discovery, Medicare proposes steep 340B drug payment cuts, and more biotech news

Franklin/AP By Theresa Gaffney and Chelsea CirruzzoJuly 2, 2026 Theresa Gaffney[email protected]Theresa is the lead…

Anthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific…

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of…

The Trump administration's grand bargain with drugmakers isn't working out as planned.

Kennedy Jr. speaks after President Trump signed the Great American Recovery Initiative in January. Manage alerts for…

“There are better ways for schools to protect student athletes,” writes Katherine Hofmann.

“This administrative logic is hopelessly out of touch with the empirical reality of American health care,” writes…

You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Abivax on Monday night disclosed additional…

States argue the rules will make it too hard for people to get the Medicaid coverage they're entitled too.

Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout

The Supreme Court’s ruling on Roundup shows science and law use the same word — causation — while asking different…

Rose BroderickJune 26, 2026 Disability in Health Care Reporting Fellow O. Confidential tips can be sent to Rose on…

Under President Trump, political leaders are exerting more control across federal health agencies.

The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that…

The unusual access to an experimental drug has captured the attention of the American public as well.

In this edition of STAT Health Tech: FDA drops enforcement against Whoop, more AI devices get FDA 'breakthrough'…
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.